Investor ContactMarcy NanusThe Trout Group, LLC646-378-2927 email@example.com Media Contact Jennifer Conrad or Douglas MacDougall MacDougall Biomedical Communications781-235-3060 firstname.lastname@example.orgSOURCE Protalix BioTherapeutics, Inc.
Protalix BioTherapeutics' Taliglucerase Alfa Phase III Results Published In Blood, The Journal Of The American Society Of Hematology
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.